Article Text

PDF
CP-139 Effect of cancelling elective cardioversion and catheter ablation in patients with atrial fibrillation
  1. V Collings,
  2. I Hafiz,
  3. S Dhindsa
  1. Guy’s and St Thomas’ NHS Foundation Trust, Pharmacy, London, UK

Abstract

Background Electrical cardioversion (ECV) and catheter ablations are elective non-pharmacological approaches that aim to restore sinus rhythm (SR) in atrial fibrillation (AF) patients. Patients require anticoagulation peri-procedurally to prevent thrombo-embolic events.

Purpose To evaluate the reasons behind procedure cancellations in patients with AF and investigate the impact on patient outcome post-procedure, including its association with procedure waiting time and cost.

Material and methods A retrospective service evaluation was conducted at a UK teaching hospital. Appointments for ECV and ablation procedures from August 2012 to August 2013 were studied; 72 patients (cancellation group) experienced cancellations and 89 patients (control group) experienced none. ‘Electronic Patient Records’ and ‘TOMCAT’ software were used to obtain data. For the Mann-Whitney U and chi-squared tests, p < 0.05 was considered significant.

Results Of the 98 reasons identified for cancellations, high and low international normalised ratio (INR) ranges were the most common at n = 14 (14%) and n = 12 (12%), respectively. Patients who experienced a longer waiting time were more likely to experience subsequent cancellations (p = 0.006); more patients from the cancellation group breached the 18-week target waiting limit (p < 0.001). Procedure cancellations showed no significant impact on reaching sinus rhythm or experiencing recurrences of arrhythmia (p = 0.946) however a total loss in revenue resulted of around €215,000.

Conclusion Prescribing direct-acting oral anticoagulants (DOAC) may prevent INR-related cancellations and this is an expanding area of use. Post-marking surveillance is still ongoing but the risk of poor patient adherence to treatment and post-procedure bleeding needs to be balanced with the potentials gains to the hospital department.

References and/or Acknowledgements 1 Camm AJ, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology. Eur Heart J 2010;19(31):2369–429

No conflict of interest.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.